運(yùn)用創(chuàng)新轉(zhuǎn)譯醫(yī)學(xué)研發(fā)模式，專注於新藥臨床前至人體臨床藥效驗證開發(fā)階段的生技新藥公司。

BRIM is a virtually operating company, focusing on developing new drugs in various areas, including oncology and infectious disease. BRIM's pipeline is generated from sourcing deals both within and outside of Taiwan, with its experienced team surveying many small molecules, peptides, biologics, and platform technologies at the lead optimization stage.